Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Polycythemia Vera

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

  • Emad Ibrahim, MD, Inc, Redlands, California, United States

  • US Oncology Inc, Englewood, Colorado, United States

  • American Oncology Partners of Maryland, PA, Bethesda, Maryland, United States

    Contact: Study coordinator (Victor Priego)
  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

  • The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Oncology Associates of Oregon, P.C., Eugene, Oregon, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

  • Texas Oncology (Webster) - USOR, Houston, Texas, United States

  • Texas Oncology-Denison Cancer Center, Sherman, Texas, United States

    Contact: Principal Investigator (Amir Faridi)
  • University of Utah - Huntsman Cancer Institute - PPDS, Salt Lake City, Utah, United States

  • The James Cancer Hospital and Solove Research Institute, Roanoke, Virginia, United States

  • VA Puget Sound Health Care System - NAVREF - PPDS, Seattle, Washington, United States

  • Landesklinikum Wiener Neustadt, Wiener Neustadt, Lower Austria, Austria

  • Medizinische Universitat Wien (Medical University of Vienna), Vienna, State of Vienna, Austria

  • Ordensklinikum Linz GmbH Elisabethinen, Linz, Upper Austria, Austria

  • Klinikum Wels-Grieskirchen GmbH, Wels, Upper Austria, Austria

  • Acibadem City Clinic Multiprofile Hospital for Active Treatment Tokuda, Sofia, Sofia-Grad, Bulgaria

  • University Multiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv, Bulgaria

  • University Multiprofile Hospital for Active Treatment - Prof. Dr. Stoyan Kirkovich AD, Stara Zagora, Bulgaria

  • Clinical Hospital Dubrava, Zagreb, City of Zagreb, Croatia

  • Clinical Hospital Center Rijeka - PPDS, Rijeka, Croatia

  • Clinical Hospital Center Rijeka, Rijeka, Croatia

  • General Hospital Sibenik, Šibenik, Croatia

  • Centre Hospitalier de Saint-Quentin, Saint-Quentin, Aisne, France

  • CHU de Nice, Nice, Alpes-Maritimes, France

  • Centre Hospitalier de Troyes, Troyes, Aube, France

  • Hôpital Bretonneau, Tours, Indre-et-Loire, France

  • CHU Nantes, Nantes, Loire-Atlantique, France

  • CHU Angers, Angers, Maine-et-Loire, France

  • CHU Amiens Hôpital Sud, Amiens, Somme, France

  • Hôpital Saint Louis, Paris, France

  • Hopital d'Argenteuil, Argenteuil, Île-de-France Region, France

  • Medizinische Fakultät Mannheim der Universität Heidelberg, Universitätsmedizin Mannheim, Mannheim, Baden-Wurttemberg, Germany

  • Gemeinschaftspraxis Hämatologie - Onkologie, Dresden, Saxony, Germany

  • Universitätsmedizin Halle, Universitätsklinikum Halle, Klinik für Innere Medizin IV, Halle, Saxony-Anhalt, Germany

  • OncoResearch Lerchenfeld GmbH, Hamburg, Germany

  • Gyor-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház, Győr, Győr-Moson-Sopron, Hungary

  • Szabolcs-Szatmár-Bereg Vármegyei Oktatókórház, Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

  • Tolna Vármegyei Megyei Balassa János Kórház, Szekszárd, Tolna County, Hungary

  • Cork University Hospital, Cork, Ireland

  • Connolly Hospital Blanchardstown, Dublin, Ireland

  • Mater Misericordiae University Hospital, Dublin, Ireland

  • Hadassah Medical Center - PPDS, Jerusalem, Jerusalem, Israel

  • Assuta Medical Center, Tel Aviv, Tel Aviv, Israel

  • Bnai Zion Medical Center, Haifa, Israel

  • Carmel Medical Center, Haifa, Israel

  • Istituto Tumori "Giovanni Paolo II" I.R.C.C.S., Bari, Apulia, Italy

    Contact: Principal Investigator (Paolo Ditonno)
  • Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Calabria, Italy

  • Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico, Bologna, Emilia-Romagna, Italy

  • Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l, Meldola, Emilia-Romagna, Italy

  • Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy

  • Azienda Sanitaria Universitaria Friuli Centrale, Udine, Friuli Venezia Giulia, Italy

  • Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Lazio, Italy

  • Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Lombardy, Italy

    Contact: Study coordinator (Federico Lussana)
  • Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Lombardy, Italy

  • Azienda Sanitaria Ospedaliera S. Croce e Carle, Cuneo, Piedmont, Italy

  • A.O.U. Maggiore della Carità, Novara, Piedmont, Italy

  • Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Piedmont, Italy

  • Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco di Catania, Catania, Sicily, Italy

  • Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Sicily, Italy

  • Azienda Ospedaliero Universitaria delle Marche, Ancona, The Marches, Italy

  • Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany, Italy

  • Spaarne Gasthuis, Hoofddorp, North Holland, Netherlands

  • Medisch Spectrum Twente, Enschede, Overijssel, Netherlands

  • Albert Schweitzer Ziekenhuis, Dordrecht, South Holland, Netherlands

  • Indywidualna Specjalistyczna Praktyka Lekarska Tomasz Woźny, Poznan, Poland

  • Specjalistyczny Szpital im. dra Alfreda Sokołowskiego, Wałbrzych, Poland

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza- Radeckiego we Wrocławiu, Wroclaw, Poland

  • Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia

  • Clinical Hospital Center Zemun, Belgrade, Serbia

  • University Clinical Center of Serbia, Belgrade, Serbia

  • University Clinical Center Nis, Niš, Serbia

  • Clinical Center of Vojvodina, Novi Sad, Serbia

  • ICO Badalona-H.U. Germans Trias i Pujol, Badalona, Barcelona, Spain

  • Hospital General Universitario Dr. Balmis, Alicante, Spain

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

  • Hospital Universitario Virgen de la Victoria, Málaga, Spain

  • Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain

  • Medical Park Bahcelievler Hastanesi, Bahçelievler, Istanbul, Turkey (Türkiye)

  • Ege Universitesi Tip Fakultesi, Bornova, İzmir, Turkey (Türkiye)

    Contact: Principal Investigator (Mahmut Tobu)
  • VM Medical Park Mersin Hospital - Ataturk, Mezitli, Mersin, Turkey (Türkiye)

    Contact: Study coordinator (Anil Tombak)
    Contact: Principal Investigator (Anil Tombak)
  • Namik Kemal Universitesi Saglik Uygulama ve Arastirma Merkezi, Altınova, Terkirdag, Turkey (Türkiye)

    Contact: Study coordinator (Seval Akapinar)
    Contact: Principal Investigator (Seval Akapinar)
  • Belfast City Hospital, Belfast, United Kingdom

  • Pilgrim Hospital, Boston, United Kingdom

    Contact: Study coordinator (Ciro Rinaldi)
    Contact: Principal Investigator (Ciro Rinaldi)
  • Imperial College Healthcare NHS Trust, London, United Kingdom

  • Milton Keynes University Hospital, Milton Keynes, United Kingdom

    Contact: Study coordinator (Magbor Akanni)
    Contact: Principal Investigator (Magbor Akanni)
  • University of Oxford - The Weatherall Institute of Molecular Medicine (WIMM), Oxford, United Kingdom

  • Southampton General Hospital, Southampton, United Kingdom

    Contact: Principal Investigator (Srinivasan Narayanan)